A Study of LY3023414 and Necitumumab in Squamous Lung Cancer

Clinical trial NCT02443337 · TERMINATED

Trial details

NCT number: NCT02443337
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Metastatic

Start date: 2015-07-01
Primary completion: 2017-09-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.